Company attributes
Industry
B2X
CEO
Founder
Pitchbook URL
Legal Name
CellCentric Ltd.
Legal classification
Date Incorporated
October 30, 2003
Spun Out From
Number of Employees (Ranges)
11 – 50
Email Address
Phone Number
Number of Employees
8
Full Address
Oxford Science Park Magdalen Centre Oxford OX4 4GA United Kingdom0
Chesterford Research Park Little Chesterford Cambridge CB10 1XL England, United Kingdom0
No. 1 Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom0
Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
Incorporation Reference
04948632
Investors
Founded Date
2003
Total Funding Amount (USD)
463,531,754
243,531,754
Latest Funding Round Date
May 19, 2025
May 6, 2026
Competitors
Patents Assigned (Count)
3
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
120,000,000
220,000,000
UKSIC Code
72110
Wikidata ID
CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind, p300/CBP inhibitor for the treatment of specific cancer types.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
